Fluvoxamine maleate in the treatment of depression: A single-center, double-blind, placebo-controlled comparison with imipramine in outpatients

Journal of Clinical Psychopharmacology

Volumn 16, Issue 2, 1996, Pages 113-120

  Claghorn, James L ^a   Earl, Craig Q ^a   Walczak, Donna D ^a   Stoner, Kim A ^a   Wong, Lung Fai ^a   Kanter, Donald ^a   Houser, Vincent P ^a  

^a Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE; IMIPRAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOMNOLENCE; URINE RETENTION; VERTIGO; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIDEPRESSIVE AGENTS, TRICYCLIC; DEPRESSIVE DISORDER; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUVOXAMINE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED; PERSONALITY INVENTORY; TREATMENT OUTCOME;

EID: 0029923907     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199604000-00003     Document Type: Article

References (29)

1. Wilde MI, Plosker GL, Benfield P. Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness. Drugs 1993;46:895-924.
2. Molewijk HE, Van der Heijden JAM. Psychopharmacological profile of fluvoxamine. Medidact, 1988.
3. Van der Heijden JAM, Molewijk E, Olivier B. Strain differences in response to drugs in the tail suspension test for antidepressant activity. Psychopharmacology (Berl) 1987;92:127-30.
4. Itil TM, Shrivastava R, Mukherjee S, Coleman BS, Michael ST. A double-blind placebo-controlled study of fluvoxamine, imipramine in out-patients with primary depression. Br J Clin Pharmacol 1983;15:433S-8S.
5. Lapierre YD, Browne M, Horn E, Oyewumi LK, Sarantidis D, Roberts N, Badoe K, Tessier P, Treatment of major affective disorder with fluvoxamine. J Clin Psychiatry 1987;48:65-8.
6. Feighner JP, Boyer WF, Merideth CH, Hendrickson GG. Placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression. Int Clin Psychopharmacol 1989;4:239-44.
7. Dominguez RA, Goldstein BJ, Jacobson AF, Steinbook RM. A double-blind placebo-controlled study of fluvoxamine, imipramine in depression. J Clin Psychiatry 1985;46:84-7.
8. Amin MM, Ananth JV, Coleman BS, Darcourt G, Farkes T, Goldstein BJ, Lapierre YD, Paykel ES, Wakelin JS. Fluvoxamine: antidepressant effects confirmed in a placebo-controlled international study. Clin Neuropharmacol 1984;7:580-1.
9. Cassano GB, Conti L, Massimetti G, Mengali F, Waekelin JS, Levine J. Use of a standarized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine and placebo [abstract]. Psychopharmacol Bull 1986;22:52-8.
10. Wernicke JF, Dunlop SR, Dornseif BE. Fixed-dose fluoxetine therapy for depression. Psychopharmacol Bull 1087;23:164-8.
11. Wernicke JF, Dunlop SR, Dornseif BE. Low-dose fluoxetine therapy for depression. Psychopharmacol Bull 1988;24:183-8.
12. Beasley CM, Bosomworth JC, Wernicke JF. Fluoxetine: relationships among dose, response, adverse events, and plasma concentrations in the treatment of depresssion. Psychopharmacol Bull 1990;26:18-24.
13. Fabre LF, Putman HP. A fixed-dose clinical trial of fluoxetine in out-patients with major depression. J Clin Psychiatry 1987;48:406-8.
14. Benfield P, Heel RC, Lewis SP. Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986;32:481-508.
15. Kiev A. A double-blind, placebo-controlled study of paroxetine in depressed outpatients. J Clin Psychiatry 1992;53[2 suppl]:27-9.
16. Smith WT, Glaudin V. A placebo-controlled trial of paroxetine in the treatment of major depression. J Clin Psychiatry 1992;53[2 suppl]:36-9.
17. Fabre LF. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients. J Clin Psychiatry 1992;53[suppl]:40-3.
18. Cohn JB, Wilcox CS. Paroxetine in major depression: a double-blind trial with imipramine and placebo. J Clin Psychiatry 1992;53[suppl]52-6.
19. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
20. Fankhauser MP, German ML. Understanding the use of behavioral rating scales in studies evaluating the efficacy of antianxiety and antidepressant drugs. Am J Hosp Pharm 1987;44:2087-100.
21. Murphy BL, Pickar D, Alterman IS. Methods for the quantitative assessment of depressive and manic behavior. In: Burdoch EI, Sudelovsky A, Gershon S, eds. The behavior of psychiatric patients. Quantitative techniques for evaluation. New York: Marcel Dekher, Inc., 1982:355-92.
22. Knesevich JW, Biggs JT, Clayton PJ. Validity of the Hamilton Rating Scale for Depression. Br J Psychiatry 1977;131:49-52.
23. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-9.
24. Raskin A, Crook TH, Sensitivity of rating scales completed by psychiatrists, nurses and patients to antidepressant drug effects. J Psychiatr Res 1976;13:31-41.
25. Neter J, Wasserman W, Kutner M, Implementation of ANOVA model (nonnormality). In: Neter J, ed. Applied linear statistical models: regression, analysis of variance, and experimental designs, 2nd ed. Homewood, IL: Richard D. Irwin, 1985:624.
26. Snedecor GW, Cochran WG. Attribute data with more than one degree of freedom. In: Snedecor GW, Cochran WG, eds. Statistical methods. 6th ed. Ames, IA: Iowa State University Press, 1967:244.
27. Heeren T, D'Agostino R, Robustness of the two independent samples t-test when applied to ordinal scaled data Stat Med 1987;6:79-90.
28. Silverberg AR. The analysis of variance for discrete data. Proceedings: Joint Statistical Meetings 1989:1-9.
29. Guy W. ECDEU assessment manual for psychopharmacology. NIMH Publ. no. 76-338 (ADM). Washington, DC: DHEW, 1916.